SELLAS Life Sciences (SLS) Reports Preliminary Data Showing

SELLAS Life Sciences (SLS) Reports Preliminary Data Showing Clinical Benefit from Phase 1/2 Clinical Trial of Galinpepimut-S (GPS) in Combination with Keytruda

SELLAS Life Sciences (SLS) Reports Preliminary Data Showing Clinical Benefit from Phase 1/2 Clinical Trial of Galinpepimut-S (GPS) in Combination with Keytruda

streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

United States , China , Canada , Angelos Stergiou , Jeffreys Weber , Contactraquel Cona Michaela Fawcett , Langone Health , Perlmutter Cancer Center At New York University , Company Wilms , Genfleet Therapeutics Shanghai Inc , Nasdaq , Merck Co Inc , Life Sciences Group Inc , Melanoma Research Program Center , Memorial Sloan Kettering Cancer Center , Wall Street , Sciences Group , Clinical Trial Collaboration , Supply Agreement , Top Line Clinical , Deputy Director , Perlmutter Cancer Center , New York University , Scientific Advisory , Ovarian Cancerovarian , Genfleet Therapeutics , Looking Statementsthis , Annual Report , Contactraquel Cona ,